The latest celebrity weight-loss drug to be given the nod in Hong Kong will be available in December, but experts cautioned ...

You need the best health care providers to ensure a proper hormone balance. Here are the top endocrinologists on.

SGLT2 inhibitors and GLP-1 receptor agonists exhibit renoprotective effects in patients with CKD with and without diabetes.

The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...

At the center of this fight is how the FDA regulates a possible "functional cure" for Type 1 diabetes and determines who gets ...

In interviews with Reuters, eight U.S. obesity specialists at universities and large health systems described a different ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy ...

Unplanned pregnancies are still being reported among people using GLP-1 drugs, but now fertility specialists are ...

These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates ...

Analysts have struggled to estimate the size of the compounded market for weight-loss drugs because their sale is not tracked ...

The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versi ...